Suppr超能文献

肝硬化病因与肝细胞癌发展模式之间关联的证据。

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.

作者信息

Benvegnù L, Noventa F, Bernardinello E, Pontisso P, Gatta A, Alberti A

机构信息

Department of Clinical and Experimental Medicine, Clinica Medica 5 degrees, University of Padova, Italy.

出版信息

Gut. 2001 Jan;48(1):110-5. doi: 10.1136/gut.48.1.110.

Abstract

BACKGROUND

Patients with liver cirrhosis are at significant risk of hepatocellular carcinoma (HCC) that may develop as well defined nodular lesions or as more aggressive infiltrating tumours.

AIM

To compare prospectively risk factors associated with nodular or infiltrating HCC in cirrhotic patients.

PATIENTS AND METHODS

We studied 370 patients with cirrhosis, followed prospectively by periodic ultrasound (US) of the liver, for a mean period of 74.6 (SD 32.4) months to define the incidence and patterns of HCC development. Patients who developed HCC were compared according to tumour pattern using univariate and multivariate analysis.

RESULTS

Sixty one (16.5%) patients developed HCC: HCC was classified as nodular in 49 (80.3%) and infiltrating in 12 (19.7%) according to US and computerised tomography (CT) imaging. The five and 10 year cumulative probabilities were 8.1% (95% confidence interval (CI) 5. 2%-11%) and 25.2% (15.0-35.4%) for nodular HCC and 2.1% (0.5-3.7%) and 6.9% (2.1-11.7%) for infiltrating HCC. Patients with infiltrating HCC were younger than those with nodular HCC (59.5 v 66. 2 years, 95% CI 55.2-63.8 and 64.1-68.3 years; p=0.014). Using multivariate analysis, development of nodular HCC was associated with older age (p=0.0002; relative risk (RR) 3.1; 95% CI 1.6-5.2), longer duration (p=0.09; RR 2.6; 95% CI 1.8-3.4), and more advanced stage (p=0.002; RR 2.5; 95% CI 1.3-4.5) of cirrhosis but not with the aetiology of liver disease. In contrast, development of infiltrating HCC appeared to be unrelated to age or disease duration or stage, while it was associated with hepatitis B virus infection (p=0.07; RR 3.96; 95% CI 1.1-5.2) and with hepatitis B/hepatitis C virus coinfection (p=0.0007; RR 16.9; 95% CI 3.8-36.7).

CONCLUSIONS

In liver cirrhosis, we identified two patterns of HCC developing with distinct risk factors. Nodular HCC was related to the cirrhotic process per se independent of aetiological factors and may depend on the proliferative activity within regenerative nodules, while the infiltrating form of HCC was linked to hepatitis B virus infection and may reflect more direct virus induced carcinogenesis.

摘要

背景

肝硬化患者患肝细胞癌(HCC)的风险很高,HCC可能发展为边界清晰的结节性病变或侵袭性更强的浸润性肿瘤。

目的

前瞻性比较肝硬化患者发生结节性或浸润性HCC的相关危险因素。

患者与方法

我们研究了370例肝硬化患者,对其肝脏进行前瞻性定期超声(US)检查,平均随访74.6(标准差32.4)个月,以确定HCC发生的发生率和模式。根据肿瘤模式,采用单因素和多因素分析对发生HCC的患者进行比较。

结果

61例(16.5%)患者发生HCC:根据US和计算机断层扫描(CT)成像,49例(80.3%)HCC被分类为结节性,12例(19.7%)为浸润性。结节性HCC的5年和10年累积概率分别为8.1%(95%置信区间(CI)5.2%-11%)和25.2%(15.0-35.4%),浸润性HCC分别为2.1%(0.5-3.7%)和6.9%(2.1-11.7%)。浸润性HCC患者比结节性HCC患者年轻(59.5岁对66.2岁,95%CI 55.2-63.8岁和64.1-68.3岁;p=0.014)。采用多因素分析,结节性HCC的发生与年龄较大(p=0.0002;相对风险(RR)3.1;95%CI 1.6-5.2)、病程较长(p=0.09;RR 2.6;95%CI 1.8-3.4)和肝硬化分期较晚(p=0.002;RR 2.5;95%CI 1.3-4.5)有关,但与肝病病因无关。相比之下,浸润性HCC的发生似乎与年龄、病程或分期无关,而与乙型肝炎病毒感染(p=0.07;RR 3.96;95%CI 1.1-5.2)和乙型肝炎/丙型肝炎病毒合并感染(p=0.0007;RR 16.9;95%CI 3.8-36.7)有关。

结论

在肝硬化中,我们发现了两种具有不同危险因素的HCC发展模式。结节性HCC与肝硬化本身相关,独立于病因因素,可能取决于再生结节内的增殖活性,而浸润性HCC与乙型肝炎病毒感染有关,可能反映了更直接的病毒诱导致癌作用。

相似文献

引用本文的文献

1
Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma.浸润性肝细胞癌全身治疗的疗效
J Hepatocell Carcinoma. 2025 Jun 23;12:1221-1229. doi: 10.2147/JHC.S528897. eCollection 2025.
3
Optimizing US for HCC surveillance.优化超声用于肝细胞癌监测
Abdom Radiol (NY). 2025 Jun;50(6):2453-2463. doi: 10.1007/s00261-024-04631-y. Epub 2024 Nov 25.

本文引用的文献

2
Screening for hepatocellular carcinoma.肝细胞癌筛查
Hepatology. 1998 Jan;27(1):273-8. doi: 10.1002/hep.510270140.
3
Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study.
Gastroenterology. 1997 May;112(5):1617-23. doi: 10.1016/s0016-5085(97)70044-1.
4
Clonal analysis of precancerous lesion of hepatocellular carcinoma.肝细胞癌癌前病变的克隆分析
Gastroenterology. 1996 Aug;111(2):455-61. doi: 10.1053/gast.1996.v111.pm8690212.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验